| Product Code: ETC7218190 | Publication Date: Sep 2024 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Vasudha | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 France End Stage Renal Disease Market Overview |
3.1 France Country Macro Economic Indicators |
3.2 France End Stage Renal Disease Market Revenues & Volume, 2021 & 2031F |
3.3 France End Stage Renal Disease Market - Industry Life Cycle |
3.4 France End Stage Renal Disease Market - Porter's Five Forces |
3.5 France End Stage Renal Disease Market Revenues & Volume Share, By Type, 2021 & 2031F |
3.6 France End Stage Renal Disease Market Revenues & Volume Share, By Product, 2021 & 2031F |
3.7 France End Stage Renal Disease Market Revenues & Volume Share, By Indication, 2021 & 2031F |
3.8 France End Stage Renal Disease Market Revenues & Volume Share, By End users, 2021 & 2031F |
3.9 France End Stage Renal Disease Market Revenues & Volume Share, By Distribution Channel, 2021 & 2031F |
4 France End Stage Renal Disease Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of end-stage renal disease in France |
4.2.2 Technological advancements in renal replacement therapies |
4.2.3 Growing elderly population leading to higher incidence of renal diseases |
4.3 Market Restraints |
4.3.1 High cost associated with renal replacement therapies |
4.3.2 Limited availability of donor organs for transplantation |
4.3.3 Stringent regulatory requirements for the approval of new treatments |
5 France End Stage Renal Disease Market Trends |
6 France End Stage Renal Disease Market, By Types |
6.1 France End Stage Renal Disease Market, By Type |
6.1.1 Overview and Analysis |
6.1.2 France End Stage Renal Disease Market Revenues & Volume, By Type, 2021- 2031F |
6.1.3 France End Stage Renal Disease Market Revenues & Volume, By Calcium Succinate, 2021- 2031F |
6.1.4 France End Stage Renal Disease Market Revenues & Volume, By Mk-3866, 2021- 2031F |
6.1.5 France End Stage Renal Disease Market Revenues & Volume, By Pacritinib, 2021- 2031F |
6.1.6 France End Stage Renal Disease Market Revenues & Volume, By Sanguinate, 2021- 2031F |
6.1.7 France End Stage Renal Disease Market Revenues & Volume, By Tesidolumab, 2021- 2031F |
6.1.8 France End Stage Renal Disease Market Revenues & Volume, By Others, 2021- 2031F |
6.2 France End Stage Renal Disease Market, By Product |
6.2.1 Overview and Analysis |
6.2.2 France End Stage Renal Disease Market Revenues & Volume, By Calcimimetics, 2021- 2031F |
6.2.3 France End Stage Renal Disease Market Revenues & Volume, By Vitamin D, 2021- 2031F |
6.2.4 France End Stage Renal Disease Market Revenues & Volume, By Sterols, 2021- 2031F |
6.2.5 France End Stage Renal Disease Market Revenues & Volume, By Potassium Binders, 2021- 2031F |
6.2.6 France End Stage Renal Disease Market Revenues & Volume, By Calcium-Based, 2021- 2031F |
6.2.7 France End Stage Renal Disease Market Revenues & Volume, By Phosphate Binders, 2021- 2031F |
6.3 France End Stage Renal Disease Market, By Indication |
6.3.1 Overview and Analysis |
6.3.2 France End Stage Renal Disease Market Revenues & Volume, By End Stage Renal Disease (ESRD) Induced Hyperparathyroidism, 2021- 2031F |
6.3.3 France End Stage Renal Disease Market Revenues & Volume, By End Stage Renal Disease (ESRD) Induced Hyperkalaemia, 2021- 2031F |
6.3.4 France End Stage Renal Disease Market Revenues & Volume, By End Stage Renal Disease (ESRD) Induced Hyperphosphatemia, 2021- 2031F |
6.4 France End Stage Renal Disease Market, By End users |
6.4.1 Overview and Analysis |
6.4.2 France End Stage Renal Disease Market Revenues & Volume, By Hospitals, 2021- 2031F |
6.4.3 France End Stage Renal Disease Market Revenues & Volume, By Homecare, 2021- 2031F |
6.4.4 France End Stage Renal Disease Market Revenues & Volume, By Specialty Clinics, 2021- 2031F |
6.4.5 France End Stage Renal Disease Market Revenues & Volume, By Others, 2021- 2031F |
6.5 France End Stage Renal Disease Market, By Distribution Channel |
6.5.1 Overview and Analysis |
6.5.2 France End Stage Renal Disease Market Revenues & Volume, By Hospital Pharmacy, 2021- 2031F |
6.5.3 France End Stage Renal Disease Market Revenues & Volume, By Online Pharmacy, 2021- 2031F |
6.5.4 France End Stage Renal Disease Market Revenues & Volume, By Retail Pharmacy, 2021- 2031F |
7 France End Stage Renal Disease Market Import-Export Trade Statistics |
7.1 France End Stage Renal Disease Market Export to Major Countries |
7.2 France End Stage Renal Disease Market Imports from Major Countries |
8 France End Stage Renal Disease Market Key Performance Indicators |
8.1 Average waiting time for kidney transplantation in France |
8.2 Adoption rate of home dialysis solutions |
8.3 Number of patients opting for peritoneal dialysis over hemodialysis |
9 France End Stage Renal Disease Market - Opportunity Assessment |
9.1 France End Stage Renal Disease Market Opportunity Assessment, By Type, 2021 & 2031F |
9.2 France End Stage Renal Disease Market Opportunity Assessment, By Product, 2021 & 2031F |
9.3 France End Stage Renal Disease Market Opportunity Assessment, By Indication, 2021 & 2031F |
9.4 France End Stage Renal Disease Market Opportunity Assessment, By End users, 2021 & 2031F |
9.5 France End Stage Renal Disease Market Opportunity Assessment, By Distribution Channel, 2021 & 2031F |
10 France End Stage Renal Disease Market - Competitive Landscape |
10.1 France End Stage Renal Disease Market Revenue Share, By Companies, 2024 |
10.2 France End Stage Renal Disease Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here